Abstract 245P
Background
Currently, the ambiguous role of neutrophils (Nph) in renal cancer (RC), which is determined by their phenotype, is of considerable interest. TGF-β is able to change the expression of pro-inflammatory cytokines of Nph and their receptors, as well as stimulate the production of chemokines that attract Nph to the site of inflammation, thus forming a pro-tumor phenotype (N2). TGF-β in the tumor microenvironment induces the migration of the CD11b+ Nph population. CD11b provides adhesion, migration, degranulation of Nph. Therefore, the study was aimed at assessing the expression of the TGF-β gene, as well as CD11b receptors, by circulating Nph at different stages of RC.
Methods
The study included patients with stage I-II (n=20), stage III-IV (n=20) clear cell RC (Med 62 years) and 20 - control group (CG) (Med 60 years). The study was approved by the Ethics Committee of the IME&PС of UlSU (prot. No. 1, 01/15/2020). RNA was isolated from the fraction of peripheral blood Nph on SileksMagNA magnetic particles (Sileks, Russia). After isolation, a reverse transcription reaction was performed. Expression of the TGF-β gene was determined by quantitative reverse transcription PCR using primers (Evrogen, Russia). Immunophenotyping was performed using monoclonal antibodies to the surface antigen CD11b (Sorbent, Russia). The results were expressed as Med (Q1-Q3). Statistical processing was performed using the Statistica 13, using the Mann–Whitney U-test and the Spearman correlation coefficient (p<0.05).
Results
A significant increase in the expression of the TGF-β gene in Nph was found in patients with RC compared with the CG (0.07 (0.12-2.21) vs 0.05 (0.04-0.13), p=0, 008), and also depending on the stage: at I-II stages of RC 0.43 (0.09-1.21), at III-IV 1.91 (0.87-3.18) (p=0.05). A significant increase in the expression of CD11b on the surface of Nph was found in patients with RC 73.3±5.1% vs the CG 19.0±9.3% (p=0.001), while no relationship with the stage was found. A direct correlation was found between TGF-β and CD11b gene expression in Nph (r=0.48, p=0.01).
Conclusions
In RC, the affinity of circulating neutrophils to the tumor microenvironment increases. At the same time, the level of expression of the growth factor TGF-β increases in Nph.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
101P - The coexistence of TP53 gain-of-function mutation and hypermethylation as a poor prognostic factor in BRAF wild-type metastatic colorectal cancer
Presenter: Kota Ouchi
Session: Poster Display
Resources:
Abstract
102P - Enhancing colorectal cancer prevention in high-risk populations through faecal immunochemical test surveillance
Presenter: Li Xie
Session: Poster Display
Resources:
Abstract
103P - Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort A
Presenter: Junwei Wu
Session: Poster Display
Resources:
Abstract
104P - The value of functional MR-imaging signature model for early prediction of chemotherapy response and its guidance for regimen adjustment to improve efficacy
Presenter: Wenhua Li
Session: Poster Display
Resources:
Abstract
105P - A single-arm, phase II, multicenter study of iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors
Presenter: Weijian Guo
Session: Poster Display
Resources:
Abstract
106P - Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies
Presenter: Ying Yuan
Session: Poster Display
Resources:
Abstract
107P - Tumor-stromal ratio in a new age fibroblast activated protein PET imaging as a biomarker for prediction of response to neoadjuvant chemoradiotherapy in carcinoma rectum
Presenter: swetha Suresh
Session: Poster Display
Resources:
Abstract
108P - Detection of HER2 overexpression in colorectal cancer: Comparison of a HANDLE classic NGS panel with standard IHC/FISH
Presenter: Lijuan Luan
Session: Poster Display
Resources:
Abstract
109P - Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular status
Presenter: Andrea Pretta
Session: Poster Display
Resources:
Abstract
110P - The correlation between multi-dimensional characteristics of circulating tumor cells (CTC) and treatment response in patients with initially unresectable metastatic colorectal cancer
Presenter: Yu Liu
Session: Poster Display
Resources:
Abstract